Cargando…
Application of luteolin nanomicelles anti-glioma effect with improvement in vitro and in vivo
Glioblastoma multiforme (GBM) is one of the most common and malignant tumor. Luteolin, a polyphenolic compound, has been proposed to have anti-tumor activity against various cancers. However, the greatest obstacle in the administration of luteolin is its hydrophobicity as well as the low oral bioava...
Autores principales: | Zheng, Songping, Cheng, Yongzhong, Teng, Yan, Liu, Xiaoxiao, Yu, Ting, Wang, Yi, Liu, Jiagang, Hu, Yuzhu, Wu, Cong, Wang, Xiang, Liu, Yanhui, You, Chao, Gao, Xiang, Wei, Yuquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617413/ https://www.ncbi.nlm.nih.gov/pubmed/28977853 http://dx.doi.org/10.18632/oncotarget.18019 |
Ejemplares similares
-
Delivery luteolin with folacin-modified nanoparticle for glioma therapy
por: Wu, Cong, et al.
Publicado: (2019) -
Co-Delivery of Docetaxel and Curcumin via Nanomicelles for Enhancing Anti-Ovarian Cancer Treatment
por: Hu, Yuzhu, et al.
Publicado: (2020) -
Biodegradable micelles enhance the antiglioma activity of curcumin in vitro and in vivo
por: Zheng, Songping, et al.
Publicado: (2016) -
A BRD4 PROTAC nanodrug for glioma therapy via the intervention of tumor cells proliferation, apoptosis and M2 macrophages polarization
por: Yang, Tingting, et al.
Publicado: (2022) -
Novel brain-targeted nanomicelles for anti-glioma therapy mediated by the ApoE-enriched protein corona in vivo
por: Zhang, Zhe-Ao, et al.
Publicado: (2021)